Laura Bolkaerts

Laura Bolkaerts

Auto-generated profile, based on publicly available information

Laura Bolkaerts

Biomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMelanie Loix
Melanie Loix
SVSam Vanherle
Sam Vanherle
LBLaura Bolkaerts
Laura Bolkaerts
SVSanne Verberk
Sanne Verberk
MPMattijs Punt
Mattijs Punt
JBJeroen Bogie
Jeroen Bogie
The accumulation of foamy macrophages is a pathological hallmark of demyelinating brain disorders. Perturbed metabolism and efflux of intracellular lipids underlie the development of a harmful foamy macrophage phenotype in these disorders, yet, the molecular mechanisms underlying this dysregulation are poorly understood. Here, we show that the ubiquitin-proteasome system controls the turnover of the cholesterol efflux transporter ATP-binding cassette A1 (ABCA1) in lipid-loaded macrophages in the brain. We report that accumulation of myelin-derived lipids promotes the abundance and activity of ubiquitin-protein E3 ligase A (UBE3A) in macrophages, which stimulates ABCA1 ubiquitination and subsequent degradation. This boosts cellular lipid accumulation and induces an inflammatory macrophage phenotype that impairs remyelination. We further establish Tat-interacting protein 30 (TIP30), an inhibitor of importin β-mediated nuclear import, as an essential regulator of cytosolic UBE3A levels. Together, our findings identify UBE3A as a driver of foam cell formation and indicate that targeting UBE3A-mediated ABCA1 degradation is a promising strategy to enhance central nervous system repair.